Evidence map›Paper›PMID 33649975›Full record

ReviewArchives of toxicology2021

Krebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis.

Amin Gasmi, Massimiliano Peana, Maria Arshad, Monica Butnariu, Alain Menzel, Geir Bjørklund

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 82 citations in OpenAlex.

  1. Trial
  2. Article
  3. Citric Acid Cycle Genes and Nutrigenetics.International journal of molecular sciences · 2026
    Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Solid CaCOCurrent cancer drug targets · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Prognostic value of combining clinical factors,Annals of nuclear medicine · 2024
    Article
  15. Article
  16. Being Stung Once or Twice by Bees (International journal of molecular sciences · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 5 countries.

Amin GasmiSociété Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.ORCID http://orcid.org/0000-0003-2165-8373
Massimiliano PeanaDepartment of Chemistry and Pharmacy, University of Sassari, Sassari, Italy.ORCID http://orcid.org/0000-0002-3306-0419
Maria ArshadSociété Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.
Monica ButnariuBanat's University of Agricultural Sciences and Veterinary Medicine "King Michael I of Romania" From Timisoara, Timisoara, Romania.ORCID http://orcid.org/0000-0002-2032-5000
Alain MenzelLaboratoires Réunis, Junglinster, Luxemburg.
Geir BjørklundCouncil for Nutritional and Environmental Medicine (CONEM), Toften 24, 8610, Mo i Rana, Norway. bjorklund@conem.org.ORCID http://orcid.org/0000-0003-2632-3935
Société Francophone d’Arthroscopie · FRRosa Luxemburg Foundation · DEThe Research Council of Norway · NOUniversity of Sassari · ITUnivesity of Life Science "King Mihai I" from Timisoara · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A fundamental metabolic feature of cancerous tissues is high glucose consumption. The rate of glucose consumption in a cancer cell can be 10-15 times higher than in normal cells. Isolation and cultivation of tumor cells in vitro highlight properties that are associated with intensive glucose utilization, the presence of minimal oxidative metabolism, an increase in lactate concentrations in the culture medium and a reduced rate of oxygen consumption. Although glycolysis is suggested as a general feature of malignant cells and recently identified as a possible contributing factor to tumor progression, several studies highlight distinct metabolic characteristics in some tumors, including a relative decrease in avidity compared to glucose and/or a glutamine dependency of lactate and even proliferative tumor cells. The aim of this review is to determine the particularities in the energy metabolism of cancer cells, focusing on the main nutritional substrates, such as glucose and glutamine, evaluating lactate dehydrogenase as a potential marker of malignancy and estimating activators and inhibitors in cancer treatment.

Indexed as

AnimalsCarcinogenesisCitric Acid CycleDisease ProgressionEnergy MetabolismGlucoseGlutamineGlycolysisHumansL-Lactate DehydrogenaseNeoplasmsOxygen ConsumptionGlucoseGlutamineL-Lactate DehydrogenaseActivatorsCancerGlucoseGlycolysisInhibitorsKrebs cycle

Identifiers

PMID33649975
OpenAlexW3133586694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.